International Psoriasis Council

Advancing Knowledge. Improving Care.

Advancing Knowledge. Improving Care.

New board officers

new board officers

IPC appoints board officers for 2022

It is our pleasure to introduce our newly appointed board officers as they take on their new roles beginning January 1, 2022. IPC’s board officers lead our Board of Directors in providing leadership in the direction and operation of the IPC and develop strategies to implement our mission of improving psoriasis patient care around the globe.

Meet our 2022 officers

Craig Leonardi, MD
Central Dermatology
St. Louis, Missouri, United States
IPC President
Hervé Bachelez Headshot
Hervé Bachelez, MD, PhD
Department of Dermatology, Hôpital Saint-Louis, Imagine Institute for Human Genetic Diseases, University of Paris
Paris, France
IPC Vice President/President Elect
Claudia de la Cruz Headshot
Claudia de la Cruz, MD
Clinica Dermacross
Santiago, Chile
IPC Secretary
Bruce Strober Headshot

Bruce Strober, MD, PhD
Central Connecticut Dermatology, Cromwell, CT and Yale University, Department of Dermatology
New Haven, Connecticut, United States
IPC Treasurer

A complete list of our Board of Directors with their full biographies can be found here.

Categories

Recent Posts

New IPC Guidelines on Generalized Pustular Psoriasis

Commentary: An Oral Interleukin-23-Receptor Antagonist Peptide for Plaque Psoriasis

Introducing our Latest IPC Councilors: Experts in Psoriasis Treatment and Research

Also Read

Generalized Pustular Psoriasis

New IPC Guidelines on Generalized Pustular Psoriasis

Learn about the new global diagnostic criteria for Generalized Pustular Psoriasis as set by the International Psoriasis Council. Discover the essential features, the importance of accurate diagnosis, and the expected global impact on patient care.

Read More

Subscribe to the IPC Newsletter

Stay up-to-date on the latest research, news, and upcoming events right in your inbox.